Experience with Argon Plasma Coagulation in Treatment of Recurrent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F22%3A10444090" target="_blank" >RIV/00064203:_____/22:10444090 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11110/22:10444090

Result on the web

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Sx00CroTCb" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Sx00CroTCb</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5152/B-ENT.2022.21395" target="_blank" >10.5152/B-ENT.2022.21395</a>

Result language

angličtina

Original language name

Experience with Argon Plasma Coagulation in Treatment of Recurrent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia

Original language description

Objective: Hereditary hemorrhagic telangiectasia, or Rendu-Osler-Weber disease, is an autosomal dominant genetic disorder characterized by abnormal vessel formation. Otorhinolaryngologists often struggle with recurrent epistaxis caused by telangiectasias of the nasal mucosa. Many types of local treatments have been reported, including argon plasma coagulation, which is a non-contact electrocoagulation method used widely in surgery. The goal of this retrospective study was to enlist all patients with hereditary hemorrhagic telangiectasia treated with argon plasma coagulation for recurrent epistaxis at our department and to assess our experiences with the method. Methods: This study includes all hereditary hemorrhagic telangiectasia patients treated by argon plasma coagulation at our department starting from 2010, the year when we began using the method, until 2019. Most patients also applied topical estriol ointment in conjunction with the treatment. All patients complained of frequent heavy epistaxis before the surgery and some even required repeated blood transfusions. Results: Thirty-six patients underwent argon plasma coagulation in the monitored period (2010-2019) with mean age 54.75 and median age 59.5 years. All patients had telangiectasias in the nasal cavity. The oral mucosa and skin were also frequently affected, and 2 patients had telangiectasias in other organs. Twenty-two patients had more than 1 procedure, with a maximum of 16. All patients were satisfied with the effect of argon plasma coagulation on the severity and frequency of their epistaxis, and no major complications during or after the surgery were reported. Conclusion: Argon plasma coagulation seems to be a safe, minimally invasive, and effective method in managing recurrent epistaxis in hereditary hemorrhagic telangiectasia patients.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30206 - Otorhinolaryngology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2022

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

B-ENT

ISSN

1781-782X

e-ISSN

—

Volume of the periodical

18

Issue of the periodical within the volume

2

Country of publishing house

BE - BELGIUM

Number of pages

6

Pages from-to

85-90

UT code for WoS article

000797401700003

EID of the result in the Scopus database

2-s2.0-85130140746